financetom
Business
financetom
/
Business
/
BRIEF-Alcon And Staar Surgical Announce Expiration Of Hart-Scott-Rodino Waiting Period For Alcon'S Acquisition Of Staar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Alcon And Staar Surgical Announce Expiration Of Hart-Scott-Rodino Waiting Period For Alcon'S Acquisition Of Staar
Sep 30, 2025 6:33 AM

Sept 30 (Reuters) - ALCON AG:

* ALCON AND STAAR SURGICAL ANNOUNCE EXPIRATION OF

HART-SCOTT-RODINO WAITING PERIOD FOR ALCON'S ACQUISITION OF

STAAR

* TO PURCHASE STAAR SHARES FOR $28 PER SHARE

* DEAL REPRESENTS TOTAL EQUITY VALUE OF $1.5 BILLION

* STAAR TO HOLD VIRTUAL SPECIAL MEETING ON OCTOBER 23

* MORGAN STANLEY SERVES AS FINANCIAL ADVISOR TO ALCON

* STOCKHOLDERS OF RECORD AS OF CLOSE OF BUSINESS ON

SEPTEMBER 12,

2025, ARE ENTITLED TO VOTE AT MEETING

Source text:

Further company coverage:

(Gdansk Newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CERAWEEK-Vale expects nickel market surplus by 2028, executive says
CERAWEEK-Vale expects nickel market surplus by 2028, executive says
Mar 19, 2024
HOUSTON, March 19 (Reuters) - Brazilian miner Vale expects nickel markets to swing to a global deficit by 2028 from their current oversupply, an executive said on Tuesday. We are very strong on nickel fundamentals, Vale Chief Sustainability and Corporate Affairs Officer Emily Olson told the CERAWeek energy conference in Houston. Despite the short-term pain, we see the long-term gain....
Mitek Systems Fiscal Q4 Non-GAAP Net Income, Revenue Decline, Reiterates Fiscal 2024 Outlook
Mitek Systems Fiscal Q4 Non-GAAP Net Income, Revenue Decline, Reiterates Fiscal 2024 Outlook
Mar 19, 2024
04:26 PM EDT, 03/19/2024 (MT Newswires) -- Mitek Systems ( MITK ) reported fiscal Q4 Non-GAAP net income Tuesday of $0.15 per diluted share, down from $0.22 a year ago. Revenue for the quarter ended Sept. 30 was $37.7 million, down from $39.6 million a year earlier. The company kept its fiscal 2024 revenue outlook in the range of $180...
Dominion Lending Centres Swings Back to a Fourth-Quarter Adjusted Profit on Improved Revenue
Dominion Lending Centres Swings Back to a Fourth-Quarter Adjusted Profit on Improved Revenue
Mar 19, 2024
05:29 PM EDT, 03/19/2024 (MT Newswires) -- Dominion Lending Centres (DLGC.TO) on Tuesday said it returned to a fourth-quarter adjusted profit on higher revenue. The mortgage lender reported an adjusted profit, which excludes most one-time items, of C$1.78 million, or C$0.04 per share, in the period, compared with and adjusted loss of C$0.18 million, or nil, in the year-prior quarter....
Corvus Pharmaceuticals to Start Phase 1 Study of Atopic Dermatitis Treatment in Q2
Corvus Pharmaceuticals to Start Phase 1 Study of Atopic Dermatitis Treatment in Q2
Mar 19, 2024
05:32 PM EDT, 03/19/2024 (MT Newswires) -- Corvus Pharmaceuticals ( CRVS ) said Tuesday it expects to start a phase 1 study of soquelitinib in patients with moderate to severe atopic dermatitis in Q2. Corvus expects to enroll 64 patients who have previously failed at least one therapy and compare four different doses of the drug with placebo for safety...
Copyright 2023-2026 - www.financetom.com All Rights Reserved